Virkningen af Lyrica blev her registreret som forskellen i det månedlige antal anfald før og under behandlingen.
In epilepsy, three studies involved 1,328 patients, and the measure of the effectiveness of Lyrica was based on the difference in the monthly number of seizures before and during treatment.